Valuation Amgen Inc. Sao Paulo

Stocks

Delayed Sao Paulo Other stock markets 19:15:09 03/07/2026 +04			5-day change	1st Jan Change
69.10 ^BRL	+4.19%		+4.90%	+4.76%

07-02	Amgen Wins Preliminary Injunction to Block Colorado From Imposing Price Cap on Arthritis Drug	MT
07-02	Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial	DJ

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	126,718	140,139	154,142	140,103	176,250	201,932	-	-
Change	-	10.59%	9.99%	-9.11%	25.8%	14.57%	-	-
Enterprise Value (EV) ¹	151,990	169,779	207,811	188,229	221,725	243,637	237,989	233,086
Change	-	11.7%	22.4%	-9.42%	17.8%	9.88%	-2.32%	-2.06%
P/E	21.9x	21.7x	23.1x	34.5x	23x	24.4x	22.5x	21.6x
PBR	18.7x	38.3x	24.7x	23.8x	20.4x	18.6x	15.4x	12.7x
PEG	-	1.2x	7.36x	-0.9x	0.3x	3.12x	2.62x	5.66x
Capitalization / Revenue	4.88x	5.32x	5.47x	4.19x	4.8x	5.35x	5.22x	5.09x
EV / Revenue	5.85x	6.45x	7.37x	5.63x	6.03x	6.45x	6.15x	5.87x
EV / EBITDA	9.61x	10.5x	11.9x	9.13x	10.4x	11.4x	11x	11.2x
EV / EBIT	12.2x	13.3x	15.5x	12.5x	13.7x	14.8x	14x	13.3x
EV / FCF	18.1x	19.3x	28.2x	18.1x	27.4x	18.1x	15.8x	15.2x
FCF Yield	5.51%	5.17%	3.54%	5.52%	3.65%	5.52%	6.35%	6.56%
Dividend per Share ²	7.04	7.76	8.52	9	-	10.09	10.66	11.12
Rate of return	3.13%	2.95%	2.96%	3.45%	-	2.7%	2.85%	2.97%
EPS ²	10.28	12.11	12.49	7.56	14.23	15.34	16.66	17.3
Distribution rate	68.5%	64.1%	68.2%	119%	-	65.7%	64%	64.3%
Net sales ¹	25,979	26,323	28,190	33,424	36,751	37,762	38,714	39,694
EBITDA ¹	15,822	16,178	17,470	20,620	21,370	21,455	21,543	20,882
EBIT ¹	12,424	12,761	13,399	15,028	16,203	16,499	17,007	17,475
Net income ¹	5,893	6,552	6,717	4,090	7,711	8,232	8,865	9,294
Net Debt ¹	25,272	29,640	53,669	48,126	45,475	41,705	36,057	31,155
Reference price ²	224.97	262.64	288.02	260.64	327.31	374.15	374.15	374.15
Nbr of stocks (in thousands)	563,266	533,579	535,178	537,533	538,481	539,708	-	-
Announcement Date	07/02/22	31/01/23	06/02/24	04/02/25	03/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.49x	12.89x	26.26x	0.56%	1,082B
JOHNSON & JOHNSON	28.11x	6.46x	17.57x	2.03%	633B
ABBVIE INC.	32.2x	7.69x	15.73x	2.65%	461B
ROCHE HOLDING AG	18.2x	4.52x	11.11x	2.93%	339B
ASTRAZENECA PLC	24.21x	5.06x	14.18x	1.72%	301B
NOVARTIS AG	22.23x	5.7x	13.76x	2.76%	292B
NOVO NORDISK A/S	14.65x	5.43x	11.14x	3.42%	225B
GILEAD SCIENCES, INC.	-46.87x	5.66x	31.47x	2.47%	163B
PFIZER INC.	11.37x	3.03x	7.37x	7.2%	139B
Average	15.51x	6.27x	16.51x	2.86%	404.04B
Weighted average by Cap.	24.27x	7.94x	18.57x	2.09%